Inogen (INGN) Profit After Tax Growth (3y) (2016 - 2026)
Inogen (INGN) Profit After Tax Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.68% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 30.83% |
| 10 | Inogen | 173.63 Mn | 63.46 Mn | 37.86 Mn | -76.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.14% |
| Dec 31, 2025 | 31.92% |
| Sep 30, 2025 | 17.73% |
| Jun 30, 2025 | 3.82% |
| Mar 31, 2025 | 27.41% |
| Dec 31, 2024 | -484.71% |
| Sep 30, 2024 | -35.29% |
| Jun 30, 2024 | -41.99% |
| Mar 31, 2024 | -177.34% |
| Dec 31, 2023 | 157.67% |
| Sep 30, 2023 | -205.09% |
| Jun 30, 2023 | -81.07% |
| Mar 31, 2023 | 30.48% |
| Dec 31, 2022 | -241.39% |
| Sep 30, 2022 | -50.15% |
| Jun 30, 2022 | -34.98% |
| Mar 31, 2022 | -67.92% |
| Dec 31, 2021 | -26.37% |
| Sep 30, 2021 | -8.66% |
| Jun 30, 2021 | -70.42% |